RSS-Feed abonnieren
PDF herunterladen
DOI: 10.4103/ijmpo.ijmpo_96_19
Anaplastic Multiple Myeloma- a Morphological Challenge – A Case Series
Financial support and sponsorship Nil.
Abstract
Anaplastic multiple myeloma (AMM) is a rare and aggressive variant of plasma cell neoplasm. It is relatively treatment resistant when compared to conventional myeloma. It can arise de novo or transform from a preexisting plasma cell myeloma. Morphologically, AMM is recognized by the presence of immature plasma cells and pleomorphic, multilobated cells. Here, we present three cases of AMM.
Keywords
Anaplastic myeloma - anaplastic variant of multiple myeloma - bizarre plasma cells - multilobated plasma cellsPublikationsverlauf
Eingereicht: 13. April 2019
Angenommen: 03. Januar 2020
Artikel online veröffentlicht:
28. Juni 2021
© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Rodriguez C, Strowd RE, Grier DD. Anaplastic myeloma arising from myeloma: Successful management of two diseases in an individual. Blood 2017; 130: 5410
- 2 Sethi S, Miller I. Plasma cell myeloma with anaplastic transformation. Blood 2016; 128: 2106
- 3 Harankhedkar S, Gupta R, Rahman K. Pleomorphic multinucleated plasma cells simulating megakaryocytes in an anaplastic variant of myeloma. Turk J Haematol 2018; 35: 150-1
- 4 Ammannagari N, Celotto K, Neppalli V, Lee K, Holstein SA. Anaplastic multiple myeloma: An aggressive variant with a poor response to novel therapies. Clin Lymphoma Myeloma Leuk 2016; 16: e129-31
- 5 Rao S, Kar R, Pati HP. Anaplastic myeloma: A morphologic diagnostic dilemma. Indian J Hematol Blood Transfus 2008; 24: 188-9
- 6 Fujimi A, Nagamachi Y, Yamauchi N, Kanisawa Y. Morphological transformation of myeloma cells into multilobated plasma cell nuclei within 7 days in a case of secondary plasma cell leukemia that finally transformed as anaplastic myeloma. Case Rep Hematol 2017; 2017: 5758368